4009 Stock Overview
A healthcare provider, owns and operates a network of hospitals under the Saudi German Hospital name in the Middle East and North Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Middle East Healthcare Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س70.60 |
| 52 Week High | ر.س134.40 |
| 52 Week Low | ر.س61.50 |
| Beta | 0.41 |
| 1 Month Change | 0.14% |
| 3 Month Change | -5.87% |
| 1 Year Change | -17.52% |
| 3 Year Change | 118.58% |
| 5 Year Change | 141.78% |
| Change since IPO | -1.26% |
Recent News & Updates
With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case
Dec 16
Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist
Sep 24Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 09Recent updates
With EPS Growth And More, Middle East Healthcare (TADAWUL:4009) Makes An Interesting Case
Dec 16Investors Will Want Middle East Healthcare's (TADAWUL:4009) Growth In ROCE To Persist
Sep 24Middle East Healthcare Company (TADAWUL:4009) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 09Middle East Healthcare Company's (TADAWUL:4009) Price In Tune With Earnings
Jul 18There's Been No Shortage Of Growth Recently For Middle East Healthcare's (TADAWUL:4009) Returns On Capital
May 30Middle East Healthcare Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 09If EPS Growth Is Important To You, Middle East Healthcare (TADAWUL:4009) Presents An Opportunity
Apr 29Why Investors Shouldn't Be Surprised By Middle East Healthcare Company's (TADAWUL:4009) 27% Share Price Plunge
Apr 02There's Reason For Concern Over Middle East Healthcare Company's (TADAWUL:4009) Massive 40% Price Jump
Feb 11Returns On Capital At Middle East Healthcare (TADAWUL:4009) Have Stalled
Feb 08Should You Be Adding Middle East Healthcare (TADAWUL:4009) To Your Watchlist Today?
Jan 18Middle East Healthcare Company's (TADAWUL:4009) Revenues Are Not Doing Enough For Some Investors
Dec 28Middle East Healthcare (TADAWUL:4009) Will Want To Turn Around Its Return Trends
Sep 26Some Investors May Be Worried About Middle East Healthcare's (TADAWUL:4009) Returns On Capital
Jun 28Investors Could Be Concerned With Middle East Healthcare's (TADAWUL:4009) Returns On Capital
Mar 30Capital Allocation Trends At Middle East Healthcare (TADAWUL:4009) Aren't Ideal
Sep 20Calculating The Intrinsic Value Of Middle East Healthcare Company (TADAWUL:4009)
Jun 14Returns On Capital At Middle East Healthcare (TADAWUL:4009) Paint A Concerning Picture
Apr 18Here's What's Concerning About Middle East Healthcare's (TADAWUL:4009) Returns On Capital
Aug 10Middle East Healthcare (TADAWUL:4009) Will Will Want To Turn Around Its Return Trends
Mar 29An Intrinsic Calculation For Middle East Healthcare Company (TADAWUL:4009) Suggests It's 28% Undervalued
Mar 03Are Middle East Healthcare's (TADAWUL:4009) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 10Weak Financial Prospects Seem To Be Dragging Down Middle East Healthcare Company (TADAWUL:4009) Stock
Jan 23If You Had Bought Middle East Healthcare's (TADAWUL:4009) Shares Three Years Ago You Would Be Down 38%
Jan 05Should You Be Impressed By Middle East Healthcare's (TADAWUL:4009) Returns on Capital?
Dec 18Calculating The Fair Value Of Middle East Healthcare Company (TADAWUL:4009)
Nov 30Shareholder Returns
| 4009 | SA Healthcare | SA Market | |
|---|---|---|---|
| 7D | -3.4% | -2.3% | 0.3% |
| 1Y | -17.5% | 0.2% | -7.7% |
Return vs Industry: 4009 underperformed the SA Healthcare industry which returned 0.2% over the past year.
Return vs Market: 4009 underperformed the SA Market which returned -7.7% over the past year.
Price Volatility
| 4009 volatility | |
|---|---|
| 4009 Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in SA Market | 7.8% |
| 10% least volatile stocks in SA Market | 2.5% |
Stable Share Price: 4009 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 4009's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Ahmed Mohamed Al-Atris | saudigermanhealth.com |
Middle East Healthcare Company, a healthcare provider, owns and operates a network of hospitals under the Saudi German Hospital name in the Middle East and North Africa. It also operates, manages, and maintains medical and educational centres, rehabilitation centres, physiotherapy, pharmacies, laboratories, and radiology centres. The company also buys land to construct medical projects, as well as to establish, manage, construct, and organize exhibitions.
Middle East Healthcare Company Fundamentals Summary
| 4009 fundamental statistics | |
|---|---|
| Market cap | ر.س6.50b |
| Earnings (TTM) | ر.س211.36m |
| Revenue (TTM) | ر.س2.85b |
30.7x
P/E Ratio2.3x
P/S RatioIs 4009 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4009 income statement (TTM) | |
|---|---|
| Revenue | ر.س2.85b |
| Cost of Revenue | ر.س1.74b |
| Gross Profit | ر.س1.12b |
| Other Expenses | ر.س903.74m |
| Earnings | ر.س211.36m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.30 |
| Gross Margin | 39.07% |
| Net Profit Margin | 7.41% |
| Debt/Equity Ratio | 137.4% |
How did 4009 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 03:05 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Middle East Healthcare Company is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ibrahim Elaiwat | Aljazira Capital Company |
| Jassim Al-Jubran | Aljazira Capital Company |
| Madhu Appissa | Al Rajhi Capital |